Aczone(R) Gel 5%


United States,
www.aczone.com

Aczone(R) Gel is an aqueous topical gel formulation containing 5% dapsone developed by QLT Inc.'s wholly-owned subsidiary, QLT USA, Inc. Aczone(R) Gel 5% in controlled clinical trials included oiliness/peeling, dryness, and erythema. There were no significant differences in the adverse event rates between Aczone(R) Gel 5% and vehicle control treated patients.

Aczone Gel 5 was acquired by Allergan on July 14, 2008.

Join Mergr to view all 115 acquisitions of consumer products companies in 2008, including 47 acquisitions by private equity firms, and 68 by strategics.

Out of 60 sectors in the Mergr database, consumer products ranked 15 in number of deals in 2008. The largest consumer products acquisition in 2008 was U.S. Smokeless Tobacco - which was acquired by Altria Group for $11.7B.

Join Mergr to view this profile - and discover more consumer products acquisitions of companies like Aczone Gel 5.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 113K M&A Transactions
  • 123K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.